{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:35:13Z","timestamp":1790771713660,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03979-9","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T12:02:29Z","timestamp":1747656149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The prognostic role of albumin-bilirubin grade in the mortality of extrahepatic cholangiocarcinoma patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Fatemeh","family":"Dayyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Ajdarkosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoodreza","family":"khoonsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Nikkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Nourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Safarnezhad Tameshkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Sobhrakhshankhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"1","key":"3979_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12876-025-03596-6","volume":"25","author":"M Omouri-Kharashtomi","year":"2025","unstructured":"Omouri-Kharashtomi M, Alemohammad SY, Moazed N, Afzali Nezhad I, Ghoshouni H. Prognostic value of albumin-bilirubin grade in patients with cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 2025;25(1):19.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"3979_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/jcm10071345","volume":"10","author":"JW Lee","year":"2021","unstructured":"Lee JW, Lee JH, Park Y, Kwon J, Lee W, Song KB, et al. Prognostic impact of perioperative CA19-9 levels in patients with resected Perihilar cholangiocarcinoma. J Clin Med. 2021;10(7):1345.","journal-title":"J Clin Med"},{"issue":"2","key":"3979_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma\u2014evolving concepts and therapeutic strategies. Nat Reviews Clin Oncol. 2018;15(2):95\u2013111.","journal-title":"Nat Reviews Clin Oncol"},{"key":"3979_CR4","doi-asserted-by":"crossref","unstructured":"Vauthey J-N, Blumgart LH, editors. Recent advances in the management of cholangiocarcinomas. Seminars in liver disease; 1994: \u00a9 1994 by Thieme Medical Publishers, Inc.","DOI":"10.1055\/s-2007-1007302"},{"issue":"3","key":"3979_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","volume":"24","author":"B Sripa","year":"2008","unstructured":"Sripa B, Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol. 2008;24(3):349\u201356.","journal-title":"Curr Opin Gastroenterol"},{"key":"3979_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.critrevonc.2016.11.012","volume":"116","author":"M Squadroni","year":"2017","unstructured":"Squadroni M, Tondulli L, Gatta G, Mosconi S, Beretta G, Labianca R. Cholangiocarcinoma Crit Reviews Oncology\/hematology. 2017;116:11\u201331.","journal-title":"Cholangiocarcinoma Crit Reviews Oncology\/hematology"},{"key":"3979_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3464-5","volume":"17","author":"S Jeong","year":"2017","unstructured":"Jeong S, Cheng Q, Huang L, Wang J, Sha M, Tong Y, et al. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer. 2017;17:1\u20139.","journal-title":"BMC Cancer"},{"issue":"3","key":"3979_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/02656736.2017.1327678","volume":"34","author":"K Zhang","year":"2018","unstructured":"Zhang K, Yu J, Yu X, Han Z, Cheng Z, Liu F, et al. Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma. Int J Hyperth. 2018;34(3):292\u20137.","journal-title":"Int J Hyperth"},{"issue":"6","key":"3979_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bjs.10095","volume":"103","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhong J, Su Z, Huang J, Lu S, Xiang B, et al. Albumin\u2013bilirubin versus Child\u2013Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. J Br Surg. 2016;103(6):725\u201334.","journal-title":"J Br Surg"},{"issue":"3","key":"3979_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ijc.26407","volume":"131","author":"TJ Vogl","year":"2012","unstructured":"Vogl TJ, Naguib NN, Nour-Eldin NEA, Bechstein WO, Zeuzem S, Trojan J, et al. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: results and prognostic factors governing treatment success. Int J Cancer. 2012;131(3):733\u201340.","journal-title":"Int J Cancer"},{"issue":"8","key":"3979_CR11","doi-asserted-by":"publisher","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","volume":"95","author":"Y Peng","year":"2016","unstructured":"Peng Y, Qi X, Guo X. Child\u2013Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine. 2016;95(8):e2877.","journal-title":"Medicine"},{"key":"3979_CR12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1007\/s00270-016-1375-5","volume":"39","author":"H Hyun","year":"2016","unstructured":"Hyun H, Choi SY, Kim KA, Ko SB. Safety and efficacy of percutaneous biliary covered stent placement in patients with malignant biliary hilar obstruction; correlation with liver function. Cardiovasc Interv Radiol. 2016;39:1298\u2013305.","journal-title":"Cardiovasc Interv Radiol"},{"issue":"3","key":"3979_CR13","doi-asserted-by":"publisher","first-page":"e5895","DOI":"10.1097\/MD.0000000000005895","volume":"96","author":"H Jin","year":"2017","unstructured":"Jin H, Pang Q, Liu H, Li Z, Wang Y, Lu Y, et al. Prognostic value of inflammation-based markers in patients with recurrent malignant obstructive jaundice treated by reimplantation of biliary metal stents: a retrospective observational study. Medicine. 2017;96(3):e5895.","journal-title":"Medicine"},{"issue":"6","key":"3979_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ejso.2011.03.135","volume":"37","author":"J-M R\u00e9gimbeau","year":"2011","unstructured":"R\u00e9gimbeau J-M, Fuks D, Bachellier P, Le Treut Y, Pruvot F, Navarro F, et al. Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol (EJSO). 2011;37(6):505\u201312.","journal-title":"Eur J Surg Oncol (EJSO)"},{"issue":"6","key":"3979_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2014the ALBI grade. J Clin Oncol. 2015;33(6):550.","journal-title":"J Clin Oncol"},{"key":"3979_CR16","doi-asserted-by":"crossref","unstructured":"Ni J-Y, An C, Zhang T-Q, Huang Z-M, Jiang X-Y, Huang J-H. Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma. Int J Hyperth. 2019.","DOI":"10.1080\/02656736.2019.1567834"},{"issue":"3","key":"3979_CR17","first-page":"235","volume":"33","author":"C Yap","year":"1992","unstructured":"Yap C, Chee E, Consigliere D, Fock K. Four year experience with cholangiocarcinoma: a survey of patients, clinical presentation, management and prognosis in two hospitals. Singapore Med J. 1992;33(3):235\u20138.","journal-title":"Singapore Med J"},{"issue":"3","key":"3979_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11605-023-05578-z","volume":"27","author":"MM Munir","year":"2023","unstructured":"Munir MM, Endo Y, Lima HA, Alaimo L, Moazzam Z, Shaikh C, et al. Albumin-bilirubin grade and tumor burden score predict outcomes among patients with intrahepatic cholangiocarcinoma after hepatic resection: a multi-institutional analysis. J Gastrointest Surg. 2023;27(3):544\u201354.","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"3979_CR19","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/hepr.13673","volume":"51","author":"S Kaneko","year":"2021","unstructured":"Kaneko S, Kurosaki M, Tsuchiya K, Yasui Y, Inada K, Kirino S, et al. Prognosis of intrahepatic cholangiocarcinoma stratified by albumin\u2013bilirubin grade. Hepatol Res. 2021;51(8):902\u20138.","journal-title":"Hepatol Res"},{"issue":"3","key":"3979_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s13304-021-01080-w","volume":"74","author":"Q Pang","year":"2022","unstructured":"Pang Q, Zhou S, Liu S, Liu H, Lu Z. Prognostic role of preoperative albumin-bilirubin score in posthepatectomy liver failure and mortality: A systematic review and meta-analysis. Updates Surg. 2022;74(3):821\u201331.","journal-title":"Updates Surg"},{"key":"3979_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00270-020-02637-9","volume":"44","author":"H Yang","year":"2021","unstructured":"Yang H, Cheng Z, Han Z, Liu F, Yu X, Yu J, et al. Assessment of the outcomes of intrahepatic cholangiocarcinoma after ultrasound-guided percutaneous microwave ablation based on albumin\u2013bilirubin grade. Cardiovasc Interv Radiol. 2021;44:261\u201370.","journal-title":"Cardiovasc Interv Radiol"},{"key":"3979_CR22","doi-asserted-by":"crossref","unstructured":"Mejia A, Vivian E, Shah J, Gutierrez JCB. Albumin-bilirubin (ALBI) score and systemic immune-inflammation indexes used as pretreatment outcome predictors in patients with pancreatic ductal adenocarcinoma undergoing robotic or open Whipple procedures: a logistic regression analysis. Cureus. 2023;15(12).","DOI":"10.7759\/cureus.50949"},{"issue":"9","key":"3979_CR23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/jum.14569","volume":"37","author":"J Wang","year":"2018","unstructured":"Wang J, Wang Q, Yu G, She Q, Zhang W, Zhang J. Correlation between liver stiffness measured by shear wave elastography and child-pugh classification. J Ultrasound Med. 2018;37(9):2191\u20139.","journal-title":"J Ultrasound Med"},{"key":"3979_CR24","doi-asserted-by":"crossref","unstructured":"Nimish T, Gonzalez T, Nano O, Shin SH, Samuels S, Hussein AM. Extrahepatic cholangiocarcinoma versus intrahepatic cholangiocarcinoma: A comparison of survival outcomes and use of palliative care in diagnosed patients. American Society of Clinical Oncology; 2022.","DOI":"10.1200\/JCO.2022.40.16_suppl.e16192"},{"issue":"7","key":"3979_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/jnci\/djad046","volume":"115","author":"K Spencer","year":"2023","unstructured":"Spencer K, Pappas L, Baiev I, Maurer J, Bocobo AG, Zhang K, et al. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. JNCI: J Natl Cancer Inst. 2023;115(7):870\u201380.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"3979_CR26","doi-asserted-by":"crossref","unstructured":"Wang Y, Pang Q, Jin H, Zhou L, Hu X, Qian Z et al. Albumin-bilirubin grade as a novel predictor of survival in advanced extrahepatic cholangiocarcinoma. Gastroenterology research and practice. 2018;2018.","DOI":"10.1155\/2018\/8902146"},{"key":"3979_CR27","doi-asserted-by":"crossref","unstructured":"Durand F, Valla D, editors. Assessment of prognosis of cirrhosis. Seminars in liver disease. \u00a9 Thieme Medical; 2008.","DOI":"10.1055\/s-2008-1040325"},{"issue":"3","key":"3979_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000452846","volume":"6","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E, et al. Albumin-bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan society of hepatology: a comparison with the liver damage and Child-Pugh classifications. Liver cancer. 2017;6(3):204\u201315.","journal-title":"Liver cancer"},{"issue":"24","key":"3979_CR29","doi-asserted-by":"publisher","first-page":"e7142","DOI":"10.1097\/MD.0000000000007142","volume":"96","author":"B Chen","year":"2017","unstructured":"Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine. 2017;96(24):e7142.","journal-title":"Medicine"},{"issue":"1","key":"3979_CR30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12876-023-03017-6","volume":"23","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Qiao C, Zhao P, Zhang C. Prognostic model for oversurvival and tumor-specific survival prediction in patients with advanced extrahepatic cholangiocarcinoma: a population-based analysis. BMC Gastroenterol. 2023;23(1):422.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"3979_CR31","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"M Vithayathil","year":"2022","unstructured":"Vithayathil M, Khan SA. Current epidemiology of cholangiocarcinoma in Western countries. J Hepatol. 2022;77(6):1690\u20138.","journal-title":"J Hepatol"},{"issue":"2","key":"3979_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jso.25486","volume":"120","author":"DI Tsilimigras","year":"2019","unstructured":"Tsilimigras DI, Hyer JM, Moris D, Sahara K, Bagante F, Guglielmi A, et al. Prognostic utility of albumin-bilirubin grade for short\u2010and long\u2010term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: a multi\u2010institutional analysis of 706 patients. J Surg Oncol. 2019;120(2):206\u201313.","journal-title":"J Surg Oncol"},{"issue":"4","key":"3979_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jamcollsurg.2017.12.011","volume":"226","author":"K Sasaki","year":"2018","unstructured":"Sasaki K, Margonis GA, Andreatos N, Bagante F, Weiss M, Barbon C, et al. Preoperative risk score and prediction of long-term outcomes after hepatectomy for intrahepatic cholangiocarcinoma. J Am Coll Surg. 2018;226(4):393\u2013403.","journal-title":"J Am Coll Surg"},{"key":"3979_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08247-z","volume":"21","author":"C Tawarungruang","year":"2021","unstructured":"Tawarungruang C, Khuntikeo N, Chamadol N, Laopaiboon V, Thuanman J, Thinkhamrop K, et al. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification. BMC Cancer. 2021;21:1\u201312.","journal-title":"BMC Cancer"},{"issue":"6","key":"3979_CR35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1159\/000531557","volume":"41","author":"Q Chen","year":"2023","unstructured":"Chen Q, Zhong R, Wang Y, Kui Y, Wen X, Huang J, et al. The albumin-bilirubin score as a predictor of liver-related mortality in primary biliary cholangitis with compensated cirrhosis. Dig Dis. 2023;41(6):946\u201356.","journal-title":"Dig Dis"},{"issue":"17","key":"3979_CR36","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.7150\/jca.45633","volume":"11","author":"F Zhang","year":"2020","unstructured":"Zhang F, Lu S, Tian M, Hu K, Chen R, Zhang B, et al. Albumin-to-Alkaline phosphatase ratio is an independent prognostic indicator in combined hepatocellular and cholangiocarcinoma. J Cancer. 2020;11(17):5177.","journal-title":"J Cancer"},{"key":"3979_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07357-4","volume":"20","author":"J Zhao","year":"2020","unstructured":"Zhao J, Zhang W, Zhang J, Zhang Y, Ma W-J, Liu S-Y, et al. Survival analysis of patients with stage T2a and T2b Perihilar cholangiocarcinoma treated with radical resection. BMC Cancer. 2020;20:1\u201310.","journal-title":"BMC Cancer"},{"issue":"1","key":"3979_CR38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/jcm12010310","volume":"12","author":"J-H Han","year":"2022","unstructured":"Han J-H, Kwak J-Y, Lee S-S, Kim H-G, Jeon H, Cha R-R. Markedly elevated aspartate aminotransferase from non-hepatic causes. J Clin Med. 2022;12(1):310.","journal-title":"J Clin Med"},{"issue":"6","key":"3979_CR39","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1158\/1055-9965.1052.13.6","volume":"13","author":"TP Erlinger","year":"2004","unstructured":"Erlinger TP, Muntner P, Helzlsouer KJ. WBC count and the risk of cancer mortality in a National sample of US adults: results from the second National health and nutrition examination survey mortality study. Cancer Epidemiol Biomarkers Prev. 2004;13(6):1052\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"43","key":"3979_CR40","doi-asserted-by":"publisher","first-page":"e22827","DOI":"10.1097\/MD.0000000000022827","volume":"99","author":"F Ji","year":"2020","unstructured":"Ji F, Kang Q, Wang L, Liu L, Ke Y, Zhu Y, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients. Medicine. 2020;99(43):e22827.","journal-title":"Medicine"},{"key":"3979_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00535-015-1103-y","volume":"51","author":"M Okuno","year":"2016","unstructured":"Okuno M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, et al. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for Perihilar cholangiocarcinoma. J Gastroenterol. 2016;51:153\u201361.","journal-title":"J Gastroenterol"},{"issue":"11","key":"3979_CR42","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.hpb.2016.08.006","volume":"18","author":"EW Beal","year":"2016","unstructured":"Beal EW, Wei L, Ethun CG, Black SM, Dillhoff M, Salem A, et al. Elevated NLR in gallbladder cancer and cholangiocarcinoma\u2013making bad cancers even worse: results from the US extrahepatic biliary malignancy consortium. Hpb. 2016;18(11):950\u20137.","journal-title":"Hpb"},{"issue":"3","key":"3979_CR43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s11605-018-3892-9","volume":"23","author":"H-J Hu","year":"2019","unstructured":"Hu H-J, Jin Y-W, Zhou R-X, Ma W-J, Yang Q, Wang J-K, et al. Clinical value of inflammation-based prognostic scores to predict the resectability of hyperbilirubinemia patients with potentially resectable hilar cholangiocarcinoma. J Gastrointest Surg. 2019;23(3):510\u20137.","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"3979_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000499050","volume":"96","author":"S Hoshimoto","year":"2019","unstructured":"Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Ogata Y. Association of preoperative platelet-to-lymphocyte ratio with poor outcome in patients with distal cholangiocarcinoma. Oncology. 2019;96(6):290\u20138.","journal-title":"Oncology"},{"issue":"6","key":"3979_CR45","first-page":"3229","volume":"37","author":"Y Kitano","year":"2017","unstructured":"Kitano Y, Yamashita Y-I, Yamamura K, Arima K, Kaida T, Miyata T, et al. Effects of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios on survival in patients with extrahepatic cholangiocarcinoma. Anticancer Res. 2017;37(6):3229\u201337.","journal-title":"Anticancer Res"},{"issue":"10","key":"3979_CR46","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/jhbp.386","volume":"23","author":"M Okuno","year":"2016","unstructured":"Okuno M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, et al. Appraisal of inflammation-based prognostic scores in patients with unresectable Perihilar cholangiocarcinoma. J Hepato\u2010Biliary\u2010Pancreatic Sci. 2016;23(10):636\u201342.","journal-title":"J Hepato\u2010Biliary\u2010Pancreatic Sci"},{"issue":"1","key":"3979_CR47","doi-asserted-by":"publisher","first-page":"12691","DOI":"10.1038\/s41598-022-16727-w","volume":"12","author":"D Liu","year":"2022","unstructured":"Liu D, Heij LR, Czigany Z, Dahl E, Dulk Md, Lang SA, et al. The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma: a systematic review and meta-analysis. Sci Rep. 2022;12(1):12691.","journal-title":"Sci Rep"},{"key":"3979_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08684-w","volume":"21","author":"X Ke","year":"2021","unstructured":"Ke X, Jin B, You W, Chen Y, Xu H, Zhao H, et al. Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer. BMC Cancer. 2021;21:1\u201315.","journal-title":"BMC Cancer"},{"issue":"3","key":"3979_CR49","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.surg.2013.08.022","volume":"155","author":"Y Yokoyama","year":"2014","unstructured":"Yokoyama Y, Ebata T, Igami T, Sugawara G, Ando M, Nagino M. Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resection. Surgery. 2014;155(3):504\u201311.","journal-title":"Surgery"},{"issue":"23","key":"3979_CR50","doi-asserted-by":"publisher","first-page":"16987","DOI":"10.3390\/ijms242316987","volume":"24","author":"S-Y Ho","year":"2023","unstructured":"Ho S-Y, Liu P-H, Hsu C-Y, Tseng H-T, Huang Y-H, Su C-W, et al. Albumin-based liver reserve models vs. MELD 3.0 in prognostic prediction for hepatocellular carcinoma patients with renal insufficiency. Int J Mol Sci. 2023;24(23):16987.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03979-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03979-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03979-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T13:04:20Z","timestamp":1747659860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03979-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3979"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03979-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the ethics committee of Iran University of Medical Sciences by the number: IR.IUMS.FMD.REC.1400.616, and was conducted according to the Helsinki Declaration. Participants enrolled in the study after providing informed consent (obtained from the participants or their immediate family members) with full awareness of the study\u2019s objectives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Participants enrolled in the study after providing informed consent (obtained from the participants or their immediate family members) with full awareness of the study\u2019s objectives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}